Eikon Therapeutics, Inc. (EIKN)

NASDAQ

$6.77

$+0.08

(+1.26%)

Regular Market

Eikon Therapeutics, Inc. (EIKN) Live Price Chart

Last updated: ⁦2026-10-14 13:47:20⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Eikon Therapeutics, Inc. (EIKN) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $6.77, with a market capitalisation of $393.24M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $6.52 to $17.40. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$393.24M
Open	$6.69
Day's High	$17.40
Day's Low	$6.52
Previous Close	$6.72
Volume	38.85K
Average Volume	505.25K
P/E Ratio	--
52-Week High	$17.40
52-Week Low	$6.52
Dividend Yield	--
Earnings Date	--

Eikon Therapeutics, Inc. (EIKN) Stock Price Today

Eikon Therapeutics, Inc. (EIKN) is currently trading at $6.77 as of 2026-10-14 13:45:00, up 0.80% ($0.05) from the previous close of $6.72

During today's regular trading session, EIKN has traded between $6.52 and $17.40, with a trading volume of 38.85K shares. The current price is near the lower end of today's range.

Eikon Therapeutics, Inc. (EIKN) 7-Day Stock Price Change

Over the past seven days, Eikon Therapeutics, Inc. (EIKN) moved from $7.54 to $6.77, representing a decline of 10.16% ($0.77).

The stock traded between $6.52 and $7.84 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 542.21 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

EIKN 52-Week Price Position

Position in Range: 2.3%

52W Low$6.52

52W High$17.40

EIKN is currently trading at $6.77, placing it 2.3% of the way from its 52-week low of $6.52 to its 52-week high of $17.40. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Eikon Therapeutics, Inc. (EIKN)?

Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.

Eikon Therapeutics, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees	384
Exchange	NASDAQ
Company Website	https://www.eikontx.com

How to Buy Eikon Therapeutics, Inc. (EIKN) Stock on MEXC

Eligible investors can buy real shares of Eikon Therapeutics, Inc. (EIKN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for EIKN and Place Your Order

Open the RealStocks trading page and search for EIKN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Eikon Therapeutics, Inc. (EIKN) stock price today?

Eikon Therapeutics, Inc. (EIKN) is currently trading at $ 6.77, up 0.80% ($0.05) from the previous close of $ 6.72. Intraday prices update in real time during regular trading hours.

2.Is EIKN stock going up or down today?

As of 2026-10-14 13:45:00, EIKN is trading at $ 6.77, up 0.80% ($0.05) from its previous close of $ 6.72. The stock has traded between $ 6.52 and $ 17.40 during today’s regular session. Past price movements do not guarantee future results.

3.What is EIKN pre-market price?

As of 2026-10-14 13:45:00, EIKN is trading at $ 6.77 in pre-market trading, up 0.67% ($0.04) from the previous close of $ 6.72. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is EIKN after-hours price?

As of 2026-10-14 13:45:00, EIKN is trading at $ 6.75 in after-hours trading, up 0.37% ($0.03) from the regular-session close of $ 6.72. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is EIKN stock trading now?

EIKN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does EIKN sit relative to its 52-week high and low?

Over the past 52 weeks, EIKN has traded between a low of $ 6.52 and a high of $ 17.40. At $ 6.77, the stock is positioned 2.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Eikon Therapeutics, Inc. in?

Eikon Therapeutics, Inc. (EIKN) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Eikon Therapeutics, Inc.'s market capitalisation and where is it listed?

Eikon Therapeutics, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 393.24M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is EIKN valued in terms of P/E ratio and EPS?

EIKN trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Eikon Therapeutics, Inc. pay a dividend?

Eikon Therapeutics, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.